Dual-action GLP-1 therapy
Physician-guided tirzepatide
Access FDA-approved tirzepatide medications for better appetite control under a physician's supervision.
- Dual hormone action
- FDA-approved options
- Once-weekly dosing
- Licensed physicians
Overview
What is tirzepatide?
Tirzepatide is a dual-action medication that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, two hormones involved in appetite regulation and metabolic health.
At Ideal Physician Weight Loss, licensed physicians evaluate whether tirzepatide is clinically appropriate for your weight management goals. Prescriptions may include FDA-approved branded medications such as Zepbound® or Mounjaro®, or compounded options when medically appropriate.
Like all GLP-1 therapies, tirzepatide works best as part of a comprehensive physician-guided program that includes nutrition support, lifestyle guidance, and ongoing medical monitoring.
Dual action
How tirzepatide's dual mechanism works
GLP-1 receptor activation
Reduces appetite signals in the brain and slows gastric emptying, helping you feel fuller, longer.
Benefits
Why patients choose tirzepatide
Dual hormone action
Activates both GLP-1 and GIP receptors for enhanced appetite control and metabolic support.
Significant weight reduction
Clinical trials showed among the highest average body weight loss of any FDA-approved obesity medication studied.
Powerful appetite control
Patients often report substantial reductions in hunger and food preoccupation.
Once-weekly convenience
A single weekly injection fits easily into your routine with pharmacy-delivered supplies.
Physician oversight
Licensed doctors evaluate eligibility, prescribe, and monitor your progress throughout treatment.
Home pharmacy delivery
Prescriptions fulfilled by licensed U.S. pharmacies with discreet shipping in 3 to 5 business days.
Eligibility
Who is eligible
You may qualify if:
- Patients in states served by our licensed telehealth physicians (50 states)
May not be appropriate if:
- Certain pancreatic, gallbladder, or kidney conditions, assessed by your physician
Outcomes
Expected weight loss
Dose escalation phase. Mild GI side effects are common and usually improve. Contact your healthcare provider for guidance.
Timeline
Treatment timeline
- 1
Day 1 | Health Questionnaire & Free Care Team Call
Complete a brief questionnaire about your health history and weight goals. A care team member will connect with you to better understand your needs and guide you through the next steps.
- 2
Same Day | Physician Consultation
Meet with a licensed physician via secure telehealth to review your health profile and determine if tirzepatide is clinically appropriate for you.
- 3
If Approved | Prescription Approval & Treatment Plan
Your provider approves the prescription and selects Zepbound®, Mounjaro®, or compounded tirzepatide based on your individual needs.
- 4
3 to 5 Days | Medication Delivery
Your prescription is fulfilled through a licensed pharmacy and shipped with injection supplies and instructions.
- 5
Ongoing | Treatment Optimization
Receive regular check-ins, dose adjustments, and continued support throughout your weight management journey.
Formulations
Tirzepatide options

Zepbound®
Tirzepatide injection
FDA-approved for weight managementDual-action medication targeting GLP-1 and GIP receptors, approved for chronic weight management in adults with obesity or overweight.

Mounjaro®
Tirzepatide injection
FDA-approved for type 2 diabetesContains tirzepatide and may be prescribed for weight management when a licensed provider determines it is clinically appropriate.

Compounded tirzepatide
Same active ingredient
Physician-prescribed alternativeCompounded tirzepatide may be available when clinically appropriate and prescribed by your licensed physician.
Safety
Safety information
Tirzepatide requires a prescription and must be used under ongoing physician supervision.
Your provider conducts a thorough medical evaluation before prescribing and monitors you throughout treatment.
Doses are increased gradually over weeks to improve tolerability and reduce gastrointestinal side effects.
Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in animal studies. Discuss your personal and family history with your physician.
Not for use during pregnancy. Tell your doctor about all medications, including insulin or sulfonylureas.
Individual results may vary. All medications carry potential risks. This page is for educational purposes and does not replace professional medical advice.
Side effects
Possible side effects
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Indigestion
- Injection site reactions
Serious side effects
- Pancreatitis
- Gallbladder problems
- Kidney injury or worsening kidney disease
- Severe allergic reactions
- Low blood sugar (especially with insulin or sulfonylureas)
When to seek care: Reach out to your care team for persistent nausea or vomiting. Seek emergency care for severe abdominal pain, difficulty breathing, or signs of a serious allergic reaction.
FAQ
Tirzepatide questions
Insurance coverage varies based on your plan and medical eligibility. A $75 medical evaluation fee applies for the initial assessment. Our team can help you understand your options, and tirzepatide programs start at $399/month, including consultation, medication, and ongoing support.
Explore tirzepatide treatment
Schedule a consultation with a licensed physician to find out if tirzepatide is right for your weight loss journey.
